YMAB — Y-mAbs Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 8.61 |
| Market cap (USD) | 391,224,640 |
| P/E | -17.56 |
| ROE (%) | -24.6 |
| Net profit margin (%) | -34.65 |
| Revenue growth (%) | 3.38 |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Y-mAbs Therapeutics, Inc.
Available company fundamentals for YMAB in Biotechnology. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.